In summary, our comprehensive in vivo analyses of ASCL1 and OLIG2 loss- and gain-of-functions in primary brain tumors provide proof of concept of the combinatorial function of these two bHLH transcription factors in determining the lineage hierarchy, heterogeneity, and plasticity of GBMs. Here, ASCL1 is linked to brain neoplasm.